Beta Bionics, Inc.
BBNX · XNASCIK 1674632fmd_07H1Y5VG7D9FMC75T3FS1M6JWDManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2023 to Sep 30, 2026, 12 periods
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Total revenues | 12 | 65 | 100 |
| Cost of revenue | 6 | 29 | 45 |
| Gross profit | 6 | 36 | 56 |
| Research and development | 18 | 26 | 35 |
| Selling, general and administrative | 24 | 55 | 92 |
| Total operating expenses | 42 | 81 | 127 |
| Operating income | (36) | (45) | (72) |
| Interest and investment income | 2 | 4 | 11 |
| Other non-operating income (expense) | (8) | (10) | (2) |
| Income tax expense | – | 0 | 0 |
| Net income | (44) | (55) | (73) |